Literature DB >> 7613790

Malignancies of the genito-urinary system following renal transplantation.

R Schmidt1, D Stippel, F Krings, M Pollok.   

Abstract

OBJECTIVE: To analyse the development of malignancies of the genito-urinary system after renal transplantation. PATIENTS AND METHODS: A total of 868 renal graft recipients were followed up over a mean period of 41.8 +/- 45 months. Fifteen patients received grafts from living related donors and 853 were transplanted with kidneys from cadavers.
RESULTS: Twelve patients (1.4%) exhibited cancer of the genito-urinary system: 11 tumours were de novo malignancies. One small renal carcinoma was transplanted from a living related donor. The incidence of tumours of the genito-urinary system was 34 in 100,000 patient years in the patients treated with cyclosporin and 32 in 100,000 patient years in the conventional therapy group. Four patients died within a mean survival time of 14.4 months. Comparison of our results with sex- and age-specific incidence rates in a reference population showed an increase in malignant tumours of the genitourinary system by a factor of 7.3 in males and 11.2 in females.
CONCLUSIONS: The frequency of disorders after transplantation necessitates routine examinations in organ transplanted recipients both before and at regular intervals after transplantation, including the patient's native kidneys and cervical smears in females.

Entities:  

Mesh:

Year:  1995        PMID: 7613790     DOI: 10.1111/j.1464-410x.1995.tb07409.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

Review 1.  Risk for cancer in living kidney donors and recipients.

Authors:  Min Wang; Huai Zhang; Dan Zhou; Yong-Chao Qiao; Yan-Hong Pan; Yan-Chao Wang; Hai-Lu Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-22       Impact factor: 4.553

2.  Cyclosporin-A associated malignancy.

Authors:  Jonathan M Durnian; Rosalind M K Stewart; Richard Tatham; Mark Batterbury; Stephen B Kaye
Journal:  Clin Ophthalmol       Date:  2007-12

3.  Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient.

Authors:  Yasuhisa Hasegawa; Koji Mita; Akio Matsubara; Hideki Ohdan
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

4.  Management of Bladder Cancer following Solid Organ Transplantation.

Authors:  Jeffrey J Tomaszewski; Jeffrey A Larson; Marc C Smaldone; Matthew H Hayn; Stephen V Jackman
Journal:  Adv Urol       Date:  2011-04-18

Review 5.  Renal cell carcinoma of native kidney in Chinese renal transplant recipients: a report of 12 cases and a review of the literature.

Authors:  Chi Yuen Cheung; Man Fai Lam; King Chung Lee; Gavin Sheung Wai Chan; Kwok Wah Chan; Ka Foon Chau; Chun Sang Li; Tak Mao Chan; Kar Neng Lai
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.